General
Preferred name
Propagermanium
Synonyms
proxigermanium ()
P&D ID
PD013579
CAS
12758-40-6
122402-75-9
126595-07-1
Tags
available
contains metal
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Propagermanium is an organometallic compound of germanium that is sold as an alternative medicine for the treatment of Hepatitis B under the development of Astellas Pharma and Sanwa Kagaku Kenkyusho.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
4
BOC Sciences Bioactive Compounds
Drug Repurposing Hub
NPC Screening Collection
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
15
Molecular Weight
341.89
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
0
Aromatic Ring Count
0
cLogP
-0.21
TPSA
117.97
Fraction CSP3
0.67
Chiral centers
0.0
Largest ring
0.0
QED
0.59
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
hepatitis B
Target
CCR2
MOA
CCR agonist, interferon receptor agonist
Solubility
Soluble in DMSO
Source data
